RetinalGenix Technologies (RTGN) Cash & Current Investments (2020 - 2026)
RetinalGenix Technologies (RTGN) posted Cash & Current Investments of $180.0 for Q1 2026, down 98.78% sequentially from $14774.0 in Q4 2025, and down 95.15% YoY from $3711.0 in Q1 2025.
RetinalGenix Technologies (RTGN) Cash & Current Investments (2020 - 2026) Analysis & Trends
RetinalGenix Technologies has reported Cash & Current Investments for 7 years, with the latest figure at $180.0 in Q1 2026.
- Quarterly Cash & Current Investments fell 95.15% year-over-year to $180.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $180.0 (down 95.15% YoY) and the FY2025 annual result came in at $14774.0, up 143.8% from the prior year.
- Cash & Current Investments declined to $180.0 in Q1 2026 per RTGN's latest filing, from $14774.0 in the prior quarter.
- Over five years, Cash & Current Investments peaked at $86913.0 in Q2 2024 and troughed at $27.0 in Q2 2022.
- A 5-year average of $16107.7 and a median of $3093.5 in 2022 frame the typical range for Cash & Current Investments.
- The sharpest annual moves came in 2024 and 2025: Cash & Current Investments surged 179647.73% in 2024, then sank 99.88% in 2025.
- Over 5 years, Cash & Current Investments stood at $38.0 in 2022, then gained by 15.79% to $44.0 in 2023, then jumped by 13672.73% to $6060.0 in 2024, then soared by 143.8% to $14774.0 in 2025, then tumbled by 98.78% to $180.0 in 2026.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $180.0, $14774.0, and $92.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.45 Bn | 193.85 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 127.62 Bn | 124.14 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 73.41 Bn | 72.87 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.89 Bn | 47.64 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.33 Bn | 32.38 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 482.30 Mn |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - | 180.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 180.00 |
| Dec 31, 2025 | 14,774.00 |
| Sep 30, 2025 | 92.00 |
| Jun 30, 2025 | 839.00 |
| Mar 31, 2025 | 3,711.00 |
| Dec 31, 2024 | 6,060.00 |
| Sep 30, 2024 | 79,089.00 |
| Jun 30, 2024 | 86,913.00 |
| Mar 31, 2024 | 50,386.00 |
| Sep 30, 2023 | 44.00 |
| Jun 30, 2023 | 1,913.00 |
| Mar 31, 2023 | 7,470.00 |
| Dec 31, 2022 | 38.00 |
| Sep 30, 2022 | 3,632.00 |
| Jun 30, 2022 | 27.00 |
| Mar 31, 2022 | 2,555.00 |
| Dec 31, 2021 | 4,947.00 |
| Sep 30, 2021 | 36,578.00 |
| Dec 31, 2020 | 2,219.00 |